CEFA-DRI INTRAMAMMARY INFUSION 30MG/ML DIN 00845019
Status: Cancelled Post Market
Holder: AYERST LABORATORIES
Molecule: CEPHAPIRIN (CEPHAPIRIN BENZATHINE)
Health Canada record
| Active ingredient(s) | CEPHAPIRIN (CEPHAPIRIN BENZATHINE) 30 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intramammary |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1989 |
| Current status date | 13-Nov-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEPHAPIRIN (CEPHAPIRIN BENZATHINE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02173255 | CEFA-DRI | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Suspension | CEPHAPIRIN (CEPHAPIRIN BENZATHINE) 300 MG | Marketed |